Peptide record

TPDB77632

[Ala7-C-αGal(Ac)4]de [Ala7-C-αGal]dermorp [Ser7-O-βGlc(Ac)4]de [Ser7-O-βGlc]dermorp Dermorphin Blood-Brain Barrier modified_plain modified
11 source-reported length (unverified)
Basic Information
TPDB77632
[Ala7-C-αGal(Ac)4]de [Ala7-C-αGal]dermorp [Ser7-O-βGlc(Ac)4]de [Ser7-O-βGlc]dermorp Dermorphin
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A modified blood-brain barrier peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 11 (unverified).
C-terminal: Amidation
Sequence
YaFGYPS-NH2

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
11 source-reported length (unverified)
Linear Activity
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2 Activity
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4 Activity
Evidence Records 13 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
10.29%

Assay & Model

Capillary depletion
% capillary

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
89.71%

Assay & Model

Capillary depletion
% parenchyma

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
0.0000114

Assay & Model

Antinociception
ICV/SC ratio

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Evidence 4 Activity

Activity

Blood-Brain Barrier
0.00218 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Saturable
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.02148 ml/g

Assay & Model

Initial disrobution volume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Saturable
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
0.01398 ml/g

Assay & Model

Initial disrobution volume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 7 Activity

Activity

Blood-Brain Barrier
0.00063 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 8 Activity

Activity

Blood-Brain Barrier
0.00019 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 9 Activity

Activity

Blood-Brain Barrier
0.00035 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 10 Activity

Activity

Blood-Brain Barrier
0.0000195

Assay & Model

anti-nociception
ICV/SC ratio

Source & Reference

NA
B3Pdb

Other

human
Permeability
Evidence 11 Activity

Activity

Blood-Brain Barrier
0.0000098

Assay & Model

anti-nociception
ICV/SC ratio

Source & Reference

NA
B3Pdb

Other

human
Permeability
Evidence 12 Activity

Activity

Blood-Brain Barrier
0.0000334

Assay & Model

anti-nociception
ICV/SC ratio

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Evidence 13 Activity

Activity

Blood-Brain Barrier
0.0000089

Assay & Model

anti-nociception
ICV/SC ratio

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Additional Detail Fields 1 fields
Intravenous